Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Despite high safety hurdles and a history of failure in the field, some drug firms remain cautiously optimistic for the next wave of experimental anti-obesity agents.